| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/12/2005 | WO2005041898A2 Blood substitutes |
| 05/12/2005 | WO2005041860A2 Stem cells for use in locating and targeting tumor cells |
| 05/12/2005 | WO2005041854A2 Composition for the cosmetic treatment of age-related dermatological symptoms |
| 05/12/2005 | WO2004101776A3 Novel uses of ppar modulators and professional apcs manipulated by the same |
| 05/12/2005 | WO2004090120A3 Stem cells having increased sensitivity to sdf-1 and methods of generating and using same |
| 05/12/2005 | WO2004084828A3 Keratinocyte-fibrocyte concomitant grafting for wound healing |
| 05/12/2005 | WO2004074435A3 Methods for identifying and administering agents that bias the immune response via dendritic cells |
| 05/12/2005 | WO2003022126A3 Compositions and methods for the therapy and diagnosis of colon cancer |
| 05/12/2005 | US20050101537 Use of exendins and agonists thereof for lowering plasma lipid |
| 05/12/2005 | US20050101533 Dried blood factor composition comprising trehalose |
| 05/12/2005 | US20050101018 Viral vector encoding pigment epithelium-derived factor |
| 05/12/2005 | US20050101014 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 05/12/2005 | US20050101012 CD4+CD25+ regulatory T cells from human blood |
| 05/12/2005 | US20050100971 An immunoassay for Lactobacillus or Bifidobacterium as a probiotic antiinflammatory agent for gastrointestinal inflammation involved with inflammatory bowel disease or irritable bowel syndrome |
| 05/12/2005 | US20050100907 Method and medicament for inhibiting the expression of a given gene |
| 05/12/2005 | US20050100876 Method of cryopreservation of tissues by vitrification |
| 05/12/2005 | US20050100634 Method of producing nutritional products from human milk tissue and compositions thereof |
| 05/12/2005 | US20050100610 Use of bioactive fraction from cow urine distillate ('Go-mutra'} as a bio-enhancer of anti-infective, anti-cancer agents and nutrients |
| 05/12/2005 | US20050100536 Platelet rich plasma, no exogenous activator; sodium bicarbonate buffer, citrate dextrose anticoagulant |
| 05/12/2005 | US20050100535 Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
| 05/12/2005 | US20050100533 Promoting osteodifferentiation by coating a substrate with a solution of a synthetic peptide having -Ile-Ala residues folded in a beta-bend and mimics cell binding by collagen, incorporation into a biocompatible gel, exposure to cells; hard and soft tissue repair; dentistry |
| 05/12/2005 | US20050100531 Probiotic therapies |
| 05/12/2005 | US20050098502 filtration of coal tar to remove impurities, then adding zinc pyrithione, surfactants and carriers to form mixtures used for the treatment of skin disorders |
| 05/12/2005 | DE20221170U1 Nutritional supplement preparation, useful for improving condition of the intestinal tract, comprising probiotic culture containing living lactic acid bacteria and spice extract obtained by the ayurvedic principle containing maricha |
| 05/12/2005 | CA2558306A1 Three-dimensional mammalian ovarian follicular cell and ovarian follicle culture systems in a biocompatible matrix |
| 05/12/2005 | CA2544307A1 Pharmaceutical compositions with synchronized solubilizer release |
| 05/12/2005 | CA2544277A1 Keratin gel and the types 2, 4 and 6 of collagens of frog protein for topical use or for lamina preparation use, such as dressing or powdering in food and complements use and in cosmetic mask manufacturing or in solutions used in cosmetic formulation and medical/pharmaceutical |
| 05/12/2005 | CA2544125A1 Use of ephrins and related molecules to regulate cellular proliferation |
| 05/12/2005 | CA2543794A1 Novel multipotent stem cells and use thereof |
| 05/12/2005 | CA2543763A1 Bacterial virulence factors and uses thereof |
| 05/12/2005 | CA2543745A1 Methods of organ regeneration |
| 05/12/2005 | CA2543528A1 Placental stem cells and uses thereof |
| 05/12/2005 | CA2543125A1 Colostrum compositions and methods |
| 05/12/2005 | CA2448995A1 Device and method for attracting diseased cells and foreign substances |
| 05/11/2005 | EP1529838A1 Neural precursor and stem cells |
| 05/11/2005 | EP1529114A1 Process for preparing peptides with anti-hypertensive properties |
| 05/11/2005 | EP1529113A1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 05/11/2005 | EP1529109A2 Production of multimeric fusion proteins using a c4bp scaffold |
| 05/11/2005 | EP1529108A2 Albumin-fused ciliary neurotrophic factor |
| 05/11/2005 | EP1487967A4 Chimeric pancreas |
| 05/11/2005 | EP1250430B1 Regulatory sequence for the specific expression in dendritic cells and uses thereof |
| 05/11/2005 | EP1214416B1 Use of replication-deficient adenoviral vector in the manufacture of a medicament to boost cd8+ t cell immune response to antigen |
| 05/11/2005 | EP1124575B1 Method for the production of an antiviral agent |
| 05/11/2005 | EP0839196B1 Human ctla-8 and uses of ctla-8-related proteins |
| 05/11/2005 | EP0572478B1 Hbgad and higad polypeptides and nucleic acids and their use for the diagnosis and treatment of gad autoantigen associated diseases |
| 05/11/2005 | CN1615357A Process for the manufacture of human mononuclear phagocytic leukocytes |
| 05/11/2005 | CN1615316A Novel immunogenic mimetics of multimer proteins |
| 05/11/2005 | CN1615162A Augmentation of organ function |
| 05/11/2005 | CN1615161A Creation of tissue engineered female reproductive organs |
| 05/11/2005 | CN1615143A Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors |
| 05/11/2005 | CN1615142A Method for obtaining an anti-tumor substance from even-toe hoofed mammals |
| 05/11/2005 | CN1615127A Substituted bicyclo[3.3.1]nonan-2, 4, 9-triones as pharmaceutical active ingredients |
| 05/11/2005 | CN1613501A Multifunctional psora sterilizing liquid |
| 05/11/2005 | CN1613456A Freezing dried mycobatctericsis preparation and its preparing method and use |
| 05/11/2005 | CN1613455A Targeting microorgan micro-capsules and their preparation |
| 05/11/2005 | CN1613454A Dry scorpion venom powder and its preparation |
| 05/11/2005 | CN1201004C HER-2/neu fusion proteins |
| 05/11/2005 | CN1200742C System and compositions used in perfusion applications |
| 05/11/2005 | CN1200725C Traditional Chinese medicine for treating brain dysfunction and its producing method |
| 05/11/2005 | CN1200722C Chinese medicinal powder for treating headache |
| 05/11/2005 | CN1200721C Chinese medicineal powder for treating alopecia areata, male pattern alopecia and juvenile hoany hair |
| 05/11/2005 | CN1200718C Production method of analgesic pill for curing rheumatoid disease |
| 05/11/2005 | CN1200654C Method and device for preparing dental implant by immersion in mesenchymal cell culture |
| 05/10/2005 | US6890911 Method for the treatment of inflammation |
| 05/10/2005 | US6890897 In combination with an osteoinductive protein and a bone morphogenetic protein or a hedgehog protein to induce osteogenesis; biocompatible or biodegradable matrix |
| 05/10/2005 | US6890751 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/10/2005 | US6890728 Recovering cell components from sample; obtain cells sample, lyse, centrifuge, withdraw fluid, detect cell components |
| 05/10/2005 | US6890708 Method for improving the quality of sperm for artificial insemination of animals |
| 05/10/2005 | US6890552 Manufacturing therapeutic enclosures |
| 05/10/2005 | US6890550 Method of preventing parturient hypocalcemia in animals and compositions used therein |
| 05/10/2005 | US6890545 Fungicide and method for producing the same |
| 05/10/2005 | US6890541 Method for enhancing production performance in an animal |
| 05/10/2005 | US6890529 Edible foods, functional products or pharmaceuticals; nutraceutical; beverages |
| 05/10/2005 | US6890528 Cells for the production of helper dependent adenoviral vectors |
| 05/10/2005 | US6890512 Methods of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby |
| 05/10/2005 | CA2067330C Herpes simplex virus type 1 mutant |
| 05/06/2005 | WO2005040360A1 Blood products from mesenchymal stem cells |
| 05/06/2005 | WO2005040338A2 Constrained alkaloid immunogens and antibodies and uses thereof |
| 05/06/2005 | WO2005040188A1 Hepatocellular carcinoma specific promoter and uses thereof |
| 05/06/2005 | WO2005039608A1 Remedy ointment for piles and their manufacturing method |
| 05/06/2005 | WO2005039607A1 The use of balloonfish collagen i extractive in medical care and the preparative method of it |
| 05/06/2005 | WO2005039606A2 Moderating the effect of endotoxins |
| 05/06/2005 | WO2005039601A1 Anticancer drug from deep sea water |
| 05/06/2005 | WO2005039557A1 Use of selected amino acid-zinc complexes as anti-malarial |
| 05/06/2005 | WO2005039528A2 Composition for the treatment of arthrosis/arthritis, especially for treating joints |
| 05/06/2005 | WO2005039500A2 METHOD FOR THE PRODUCTION OF BIOACTIVE SUBSTANCES FROM THE NOVEL ACTINOMYCETE TAXON MAR2 (“Marinophilus”) |
| 05/06/2005 | WO2005039319A2 Synbiotic composition for infants |
| 05/06/2005 | WO2005002607A3 Oncolytic reoviruses for the treatment of neoplasms having activated pp2a or rac |
| 05/06/2005 | WO2004110512A3 A method for cell implantation |
| 05/06/2005 | WO2004091495A3 Compositions and methods related to production of erythropoietin |
| 05/06/2005 | WO2004032823A8 Treatment and rehydration composition which is used to limit the side effects of gastro-enteritis in adults |
| 05/06/2005 | WO2003010286A3 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 05/06/2005 | CA2546737A1 Method for the production of bioactive substances from the novel actinomycete taxon mar2 ("marinophilus") |
| 05/06/2005 | CA2543626A1 Synbiotic composition for infants |
| 05/06/2005 | CA2542452A1 Moderating the effect of endotoxins |
| 05/06/2005 | CA2542448A1 Moderating the effect of endotoxins |
| 05/06/2005 | CA2540023A1 Hepatocellular carcinoma specific promoter and uses thereof |
| 05/05/2005 | US20050096262 Helicobacter pylori adhesion inhibitor |
| 05/05/2005 | US20050095708 Using cell surface marker as tool in identification and separation of progenitor cell populations |
| 05/05/2005 | US20050095707 Using mixture comprising embryonic stem cells, neurotrophins and either cyclic adenosine monophosphate (cAMP) to propagate nervous system tissues for use in treatment of neurodegenerative disorders; regenerative medicine; tissue engineering |